文献速递妇科产科

使用子宫操纵器或腹腔内阴道切开是否会导致微创手术治疗早期宫颈癌的预后更差?

Does the Use of a Uterine Manipulator or Intracorporeal Colpotomy Confer an Inferior Prognosis in Minimally Invasive Surgery-Treated Early-stage Cervical Cancer?
PubMed 文献 · J Minim Invasive Gynecol · 2022-11-19

该回顾性队列研究纳入1169例2018至2019年接受微创根治性子宫切除术和盆腔淋巴结清扫的IB1至IB2期宫颈癌患者,中位随访34个月。单因素分析显示使用子宫操纵器组死亡风险为未使用组的7.6倍(p=.006),但多因素分析仅肿瘤大小和宫旁浸润为总生存的独立危险因素;腹腔内与保护性阴道切开者生存无统计学显著差异。

要点

  • 避免使用子宫操纵器或行保护性阴道切开者短期生存无差异。
  • 多因素分析仅肿瘤大小和宫旁浸润为总生存独立危险因素。
  • 单因素分析使用子宫操纵器组死亡风险为未使用组的7.6倍(p=.006)。

核心结论

  • 早期宫颈癌微创根治性子宫切除术中避免使用子宫操纵器或行保护性阴道切开,短期生存结局无差异。

研究设计与样本

  • 回顾性队列研究,纳入1169例术前IB1至IB2期宫颈癌患者,均接受微创根治性子宫切除术和盆腔淋巴结清扫,手术年份为2018至2019年。

主要发现

  • 患者中位年龄48岁(范围23-76岁),中位随访时间34个月(范围3.57-50.87个月)。
  • 病理分期IB1和IB2患者的2年总生存率分别为99.8%和98.8%(依据2018年国际妇产科联盟分期系统)。
  • 单因素分析显示使用子宫操纵器组死亡风险为未使用组的7.6倍(p=.006)。
  • 多因素分析显示仅肿瘤大小(p=.016;风险比2.285;95%置信区间1.166-4.479)和宫旁浸润(p=.003;风险比3.556;95%置信区间1.549-8.166)为总生存的独立危险因素。
  • 腹腔内阴道切开与保护性阴道切开患者的生存无统计学显著差异。

关键数值与推荐

  • 病理分期IB1患者2年总生存率为99.8%。
  • 病理分期IB2患者2年总生存率为98.8%。
  • 肿瘤大小风险比2.285(95%置信区间1.166-4.479,p=.016)。
  • 宫旁浸润风险比3.556(95%置信区间1.549-8.166,p=.003)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To identify whether the use of a uterine manipulator (UM) or intracorporeal colpotomy conferred inferior short-term survival among patients treated for early-stage cervical cancer. DESIGN: Retrospective cohort study. SETTING: Tertiary university-based hospital. PATIENTS: 1169 patients with stage IB1 to IB2 cervical cancer. INTERVENTIONS: All patients underwent minimally invasive radical hysterectomy and pelvic lymphadenectomy. MEASUREMENTS AND MAIN RESULTS: A total of 1169 patients diagnosed with preoperative stage IB1 to IB2 cervical cancer were primarily treated with surgery from 2018 to 2019. The eligible patients had a median age of 48 years (range, 23-76 years), and the median follow-up time was 34 months (range, 3.57-50.87 months). The 2-year overall survival rate of the patients with pathologic stage IB1 and IB2 was 99.8% and 98.8%, respectively, according to the 2018 International Federation of Gynecology and Obstetrics staging system. Univariable analysis revealed that the UM group had a 7.6-times higher risk of death than that of the manipulator-free group (p = .006), but multivariable analysis clarified that only tumor size (p = .016; hazard ratio, 2.285; 95% confidence interval, 1.166-4.479) and parametrial involvement (p = .003; hazard ratio, 3.556; 95% confidence interval, 1.549-8.166) were independent risk factors for overall survival. There was no statistically significant difference in survival between patients who underwent intracorporeal and protective colpotomy. CONCLUSION: Short-term survival outcomes in women undergoing minimally invasive radical hysterectomy for treatment of early-stage cervical cancer did not differ when a UM was avoided or when a protective colpotomy was performed.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Wang R, Hu Y, Xia H, et al. Does the Use of a Uterine Manipulator or Intracorporeal Colpotomy Confer an Inferior Prognosis in Minimally Invasive Surgery-Treated Early-stage Cervical Cancer? J Minim Invasive Gynecol. 2022. PMID: 36410659. doi:10.1016/j.jmig.2022.11.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。